Loading...
01/09 23:13
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call revealed strong financial performance with a 7% revenue increase and a 30% rise in EPS. The company executed a significant share buyback program and has a robust backlog, indicating future growth. While there are concerns about the Health & Civil segment and some uncertainties in guidance, these are outweighed by the positive financial metrics and strategic initiatives. The market is likely to react positively, with a potential stock price increase of 2% to 8% over the next two weeks.
Revenue $4.25 billion, up 7% year-over-year due to strong performance across segments, particularly in national security and digital revenues.
Adjusted EBITDA $601 million, up 23% year-over-year, with adjusted EBITDA margin increasing by 190 basis points to 14.2% due to effective execution and growth across the portfolio.
Non-GAAP Net Income $391 million, up 25% year-over-year, reflecting strong operational performance and revenue growth.
Non-GAAP Diluted EPS $2.97, up 30% year-over-year, driven by increased revenues and improved margins.
Cash Flow from Operating Activities $58 million, with free cash flow of $36 million, despite an extra week of payroll impacting cash flow.
Debt $5.1 billion with a gross leverage ratio of 2.3 times, following the issuance of $1 billion in notes to manage capital structure.
Days Sales Outstanding (DSO) 62 days, unchanged from a year ago, indicating stable cash collection despite some customer delays.
Backlog $46.3 billion, up about $3 billion from the previous quarter, reflecting a strong pipeline and adjusted backlog policy.
New Cyber Acquisition: Leidos has signed a definitive agreement to acquire a leader in full spectrum cyber, enhancing its capabilities in the cyber market.
NorthStar 2030 Strategy: Leidos is actively implementing its NorthStar 2030 strategy, focusing on five growth pillars: space and maritime, energy infrastructure, digital modernization and cyber, customized critical mission software, and managed health services.
Market Positioning: Leidos is well-positioned to align with the new administration's priorities, focusing on making government outcomes smarter and more efficient.
Growth Opportunities: The company has a robust opportunity pipeline of $226 billion, with $25 billion in proposals submitted and awaiting adjudication.
Operational Efficiency: Adjusted EBITDA margins improved to 14.2%, with a 23% year-over-year increase in adjusted EBITDA.
Revenue Growth: Organic revenue increased by 7% year-over-year, with Q1 revenues reaching $4.25 billion.
Strategic Shift: Leidos is pivoting in 2025 to lock in gains from 2024 and invest in new business momentum under the NorthStar 2030 strategy.
Share Buyback Program: Leidos executed a $500 million accelerated share repurchase agreement to enhance shareholder value.
Regulatory Issues: The company acknowledges the potential risks associated with the transition of administration, which typically leads to soft bookings and uncertainty in government contracts.
Competitive Pressures: Leidos faces competitive pressures in the cyber market, particularly with the growing complexity of cyber threats and the need for advanced solutions.
Supply Chain Challenges: The company mentions navigating an intensified macro-environment, which may imply supply chain challenges affecting operations and project execution.
Economic Factors: The current market dislocation and higher interest rates are noted as factors that could impact financial performance, including increased interest expenses.
Cybersecurity Risks: The company foresees risks associated with AI adoption, which could create vulnerabilities in cyber defenses, necessitating ongoing investment in R&D.
Market Conditions: Leidos is aware of the volatile environment and has adjusted its guidance to reflect potential unknowns, indicating a cautious approach to future revenue expectations.
NorthStar 2030 Strategy: Leidos is actively implementing its NorthStar 2030 strategy, which focuses on five growth pillars: space and maritime, energy infrastructure, digital modernization and cyber, highly customized critical mission software, and managed health services.
Acquisition: Leidos has signed a definitive agreement to acquire a leader in full spectrum cyber to enhance its cyber growth pillar, which is a key component of the NorthStar 2030 strategy.
Share Buyback: Leidos executed a $500 million accelerated share repurchase agreement to accomplish the majority of its 2025 share buyback plans.
Air Traffic Control System: Leidos is aligned with the FAA's mission to establish the next generation air traffic control system, which is a high priority for the administration.
Golden Dome Initiative: Leidos is collaborating on the Pentagon's Golden Dome initiative, focusing on building a next-generation multi-layer mission defense shield.
2025 Revenue Guidance: Leidos reaffirms its revenue guidance for 2025, projecting between $16.9 billion to $17.3 billion.
Adjusted EBITDA Guidance: The company expects adjusted EBITDA margins in the mid to high 12% range for 2025.
Non-GAAP Diluted EPS Guidance: Leidos projects non-GAAP diluted EPS between $10.35 and $10.75 for 2025.
Operating Cash Flow Guidance: Operating cash flow is expected to be approximately $1.45 billion for the year.
Backlog: Leidos reported a total backlog of $46.3 billion, with a robust opportunity pipeline of $226 billion.
Share Buyback Program: Executed a $500 million accelerated share repurchase agreement, accomplishing the majority of the 2025 share buyback plans.
The earnings call summary and Q&A highlight several positive factors: raised revenue and EBITDA margin guidance, strong cash flow, and growth in key segments like Defense Systems. The company's strategic focus on AI, automation, and capital deployment, alongside robust pipeline opportunities, further supports a positive outlook. While there are some uncertainties, such as the government shutdown, the overall sentiment is optimistic, suggesting a stock price increase of 2% to 8% over the next two weeks.
The earnings call reveals strong financial performance, particularly in defense systems, and optimistic market strategies. The Q&A highlights growth in health and maritime sectors and opportunities from government initiatives. Despite some vague responses, the overall sentiment is positive with raised margin guidance and a strong backlog. The acquisition aligns with strategic goals, and the share buyback enhances shareholder value. These factors suggest a positive stock price reaction.
The earnings call revealed strong financial performance with a 7% revenue increase and a 30% rise in EPS. The company executed a significant share buyback program and has a robust backlog, indicating future growth. While there are concerns about the Health & Civil segment and some uncertainties in guidance, these are outweighed by the positive financial metrics and strategic initiatives. The market is likely to react positively, with a potential stock price increase of 2% to 8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
